These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 13507702)

  • 1. Intermediary metabolism of phenylalanine and tyrosine in diffuse collagen diseases. I. The presence of 2,5-dihydroxyphenylpyruvic acid in the urine of patients with collagen disease.
    NISHIMURA N; YASUI M; OKAMOTO H; KANAZAWA M; KOTAKE Y; SHIBATA Y
    AMA Arch Derm; 1958 Mar; 77(3):255-62. PubMed ID: 13507702
    [No Abstract]   [Full Text] [Related]  

  • 2. 2,5-Dihydroxyphenylpyruvic acid and collagen diseases.
    TYE MJ; MASTERS S; APPEL B; WHITE H; TANAKA T KNOX WE; CULLEN A; ROSEN B
    Arch Dermatol; 1960 Mar; 81():447-52. PubMed ID: 13840083
    [No Abstract]   [Full Text] [Related]  

  • 3. [2,5-Dihydroxypyruvic acid in the urine of patients with various collagen diseases].
    GONNARD P; LEGRAND JC; GRUPPER C
    Bull Soc Fr Dermatol Syphiligr; 1959; 4():510-4. PubMed ID: 13850963
    [No Abstract]   [Full Text] [Related]  

  • 4. Intermediary metabolism of phenylalanine and tyrosine in diffuse collagen diseases. II. Influences of the low phenylalanine and tyrosine diet upon patients with collagen disease.
    NISHIMURA N; OKAMOTO H; YASUI M; MAEDA K; OGURA K
    Arch Dermatol; 1959 Oct; 80():466-77. PubMed ID: 14427316
    [No Abstract]   [Full Text] [Related]  

  • 5. Phenylalanine and tyrosine in collagen diseases. Urinary excretion of general intermediary metabolites of tyrosine in patients with collagen disease and liver disease.
    NISHIMURA N; MAEDA K; YASUI M; OKAMOTO H; MATSUNAKA M; TOSHINA H
    Arch Dermatol; 1961 Apr; 83():644-52. PubMed ID: 13729226
    [No Abstract]   [Full Text] [Related]  

  • 6. [Study of the secretion of 2,5 dihydroxyphenylpyruvic acid in collagen diseases].
    Hladíková D; Sobĕslavský C; Susta A; Havelka S
    Fysiatr Revmatol Vestn; 1968 Jul; 46(4):201-9. PubMed ID: 5691511
    [No Abstract]   [Full Text] [Related]  

  • 7. Factors affecting the excretion of metabolites of phenylalanine and tyrosine in alkaptanuria.
    HALL WK; SYDENSTRICKER VP; RAWLS K
    Fed Proc; 1948 Mar; 7(1 Pt 1):289. PubMed ID: 18915877
    [No Abstract]   [Full Text] [Related]  

  • 8. [TYROSINE METABOLISM DISORDERS IN PATIENTS WITH COLLAGEN DISEASES. II. 2,5-DIHYDROXYPHENYLPYRUVIC ACID AND ITS CLINICAL SIGNIFICANCE IN COLLAGEN DISEASES].
    KVIATKOVSKAIA AN; KAINOVA AS; MIKHAILOVA IN
    Ter Arkh; 1964 Oct; 36():76-81. PubMed ID: 14309922
    [No Abstract]   [Full Text] [Related]  

  • 9. 2,5-Dihydroxyphenyl-pyruvic acid in human urine. Preliminary identification.
    YEE HY; McCANN DS; KEECH MK; DENKO CW; BOYLE AJ
    Arch Dermatol; 1961 Aug; 84():293-301. PubMed ID: 13787288
    [No Abstract]   [Full Text] [Related]  

  • 10. [Spontaneous urinary excretion of p-hydroxyphenylpyruvic acid].
    GROS H; KIRNBERGER EJ
    Klin Wochenschr; 1954 Feb; 32(5-6):115-8. PubMed ID: 13153048
    [No Abstract]   [Full Text] [Related]  

  • 11. EXCRETION OF INDOLYL ACIDS IN PHENYLKETONURIC MONKEYS.
    BOGGS DE; MCLAY D; KAPPY M; WAISMAN HA
    Nature; 1963 Oct; 200():76. PubMed ID: 14074636
    [No Abstract]   [Full Text] [Related]  

  • 12. [Disorders of enzymatic oxidation in diseases of the muscles].
    GROS H; KIRNBERGER EJ
    Klin Wochenschr; 1954 Jul; 32(27-28):645-6. PubMed ID: 13193016
    [No Abstract]   [Full Text] [Related]  

  • 13. [Specific substance in the urine of patients with collagen disease with special reference to collagen disease and phenylalanine and tyrosine metabolism].
    Nishimura N
    Rinsho Byori; 1966 Nov; 14(11):713-9. PubMed ID: 6009727
    [No Abstract]   [Full Text] [Related]  

  • 14. [Dependence of pyruvic acid excretion on volume dosage distribution in fixed field and pendulum radiotherapy].
    BRUCKMOOSER M; KELLER L
    Strahlentherapie; 1955 Nov; 98(3):404-12. PubMed ID: 13298860
    [No Abstract]   [Full Text] [Related]  

  • 15. alpha-Ketoglutaric acid and pyruvic acid in blood, cerebrospinal fluid and urine.
    ZELNICKEK E
    Nature; 1959 Aug; 184(Suppl 10)():727. PubMed ID: 13856510
    [No Abstract]   [Full Text] [Related]  

  • 16. Urinary excretion of pyruvic acid, citric acid and alpha-ketoglutaric acid after the intravenous injection of pyruvate and fructose in diabetic patients.
    TAKANAMI A; OHYA S; GOTO Y
    Tohoku J Exp Med; 1960 Sep; 72():163-8. PubMed ID: 13774931
    [No Abstract]   [Full Text] [Related]  

  • 17. [The effect of isoniazid on glucide metabolism. IV. Excretion of pyruvic acid and alpha-ketoglutaric acid after isoniazid administration in tuberculous children and adults].
    KRULIK R; SIMANE Z; ROTTER Z
    Beitr Klin Tuberk Spezif Tuberkuloseforsch; 1962; 125():163-6. PubMed ID: 14459931
    [No Abstract]   [Full Text] [Related]  

  • 18. [Activity of ACTH in the intermediate metabolism of tryptophan and tyrosine in normal and pathological conditions (with special reference to collagen diseases)].
    MOM AM; UBALTON SP; DEGANO I
    Rev Argent Endocrinol Metab; 1959; Suppl 2():33-53. PubMed ID: 14423476
    [No Abstract]   [Full Text] [Related]  

  • 19. [Urinary excretion of indole-pyroracemic acid in normal conditions and in Fölling's disease].
    SCHREIER K; FLAIG H
    Klin Wochenschr; 1956 Nov; 34(43-44):1213. PubMed ID: 13406982
    [No Abstract]   [Full Text] [Related]  

  • 20. [Urinary excretion of pyruvic and alpha-ketoglutaric acids after intravenous administration of sodium pyruvate and fructose].
    OHYA S
    Tohoku Igaku Zasshi; 1961 Jul; 64():56-67. PubMed ID: 14481434
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.